CKMB antibody

Creatine Kinase-MB (CK-MB) is applied for auxiliary diagnosis of acute myocardial infarction and assessment of myocardial injury in patients with suspected cardiovascular diseases.   CK-MB OEM kit utilizes a two-antibody sandwich immunoassay and is applicable to chemiluminescence platforms. Specific antibodies target CK-MB epitopes to capture plasma CK-MB, delivering high sensitivity and specificity. Calibrated with high-purity recombinant CK-MB, the assay provides accurate and stable quantitative results. Serving as a classic biomarker for acute myocardial infarction diagnosis, it supports early identification and dynamic monitoring of myocardial damage for clinical auxiliary diagnosis.   Creatine Kinase-MB (CK-MB) is an isoenzyme of creatine kinase (CK) formed via post-translational modification. It is predominantly located in cardiomyocytes, with minor distribution in skeletal muscle, intestine, tongue, prostate and uterus. As a key enzyme in myocardial energy metabolism, CK-MB consists of M and B subunits (M for muscle, B for brain), accounting for 15%–30% of total CK activity. As a critical diagnostic biomarker, CK-MB has gained increasing attention, especially in cardiovascular disorders. Studies verify that both CK-MB mass and activity show good sensitivity for cardiac disease diagnosis. CK-MB mass demonstrates superior anti-interference stability compared with CK-MB activity measurement. ★Bulk reagents are available with matching raw materials.